Sens. Press OMB For Delayed Medical Device Rule

Law360, Washington (February 10, 2012, 5:36 PM EST) -- Three senators urged the White House Office of Management and Budget on Thursday to release a rule from the U.S. Food and Drug Administration on post-market medical device tracking that has been under review for over seven months.

In a letter directed to OMB Acting Director Jeffrey Zients, U.S. Sens. Herb Kohl, D-Wis.; Chuck Grassley, R-Iowa; and Richard Blumenthal, D-Conn., emphasized that the regulation could help the FDA bridge gaps in its medical device safety surveillance.

The FDA forwarded the so-called unique-device-identifier proposal to the OMB...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.